Eric Lin on Capturing Rare Cancer Cells for Early Detection and Treatment
Eric Lin on Capturing Rare Cancer Cells for Early Detection and Treatment
原文連結：
原文連結：
原文連結：
Eric Lin, CEO of Bloodscan, shares how his team developed a new system to isolate live circulating tumor cells (CTCs) — without reagents or antibodies.
Eric Lin, CEO of Bloodscan, shares how his team developed a new system to isolate live circulating tumor cells (CTCs) — without reagents or antibodies.